Banner Mobile

Validated Assays

Q2 Solutions brings more than 20 years of experience in bioanalytical services, developing robust methods to support all stages of drug discovery and development. We have developed and validated assays for a range of applications, including ADME screening/ADME testing, discovery and development metabolite identification, drug metabolism and pharmacokinetics, immunogenicity testing, biomarker analysis and characterization, and biosimilars testing. Methodologies include LC/MS bioanalysis, LC/MS/MS analysis, hybrid LC/MS assays, and immunoassay and MS-based biomarker assays. Prior to validation, each assay undergoes a formal pre-qualification process in which Q2 Solutions scientists review preliminary data and assess modifications necessary to support validation.


The link below provides a list of validated bioanalytical methods developed by Q2 Solutions to support clinical trial applications, including COVID-19 trials. In addition to listed assays, Q2 Solutions develops customized methods to meet specific challenges.

Related Thought Leaders Insights

Flexible Approaches for Biotech Companies in Clinical Trials

With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from...

Bioanalytical Immunoassay Laboratory

Our new facility, in theworld-renowned Research Triangle Park, is the flagship laboratory for Q2 Solutions. This custom-designed, 160,000-square-foot facility houses a suite of scientific solutions...

Preparation for Biotech Testing or Clinical Trials

Your clinical trial may involve samples from multiple sites to be tested by multiple laboratories. The data that flows from those tests may travel to multiple end users as well. Proper planning of...